Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06269705 · ClinicalTrials.gov registry record · Phase 3
ZILRETTA in Subjects With Shoulder Osteoarthritis
A Phase 3 study of Glenohumeral Osteoarthritis, sponsored by Pacira Pharmaceuticals.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT06269705 is a Phase 3 study of Glenohumeral Osteoarthritis that is actively recruiting participants, run by Pacira Pharmaceuticals. The registered enrollment target is 150 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT06269705, a Phase 3 study of Glenohumeral Osteoarthritis, is actively recruiting participants, sponsored by Pacira Pharmaceuticals.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo Secondary Objective: * To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, and normal saline placebo * To assess the safety of ZILRETTA in subjects with glenohumeral OA relative to normal saline placebo
Conditions Studied
Interventions
- OTHER Placebo
- DRUG ZILRETTA
Study Locations (20)
Florida
- Orthopedic Center of Palm Beach City - Atlantis
- Baptist Health Orthopedic Care - Miami Gardens - Maimi
- Infinite Clinical Research - Miami
- Gulfcoast Research Institute - Sarasota
- Clinical Research of West Florida - Tampa
- Hospital for Special Services - West Palm Beach
California
- Horizon Clinical Research - La Mesa
- Napa Pain Institute - Napa
- Stanford University - Sports Medicine Clinic - Redwood City
Arizona
- Onyx Clinical Research - Surprise
- Tucson Orthopaedic Institute (TOI) - East Office - Tucson
Alabama
- Alabama Orthopaedic Center- Research - Vestavia Hills
District of Columbia
- International Spine, Pain & Performance Center - Washington D.C.
Idaho
- Injury Care Research - Boise
Kansas
- Kansas City Bone & Joint Clinic - Overland Park - Overland Park
Louisiana
- Ochsner Sports Medicine Institute - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-02-05 |
| Est. Completion | 2026-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06269705
The ClinicalTrials.gov registry entry for NCT06269705 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glenohumeral Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06269705 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT06269705 about?
NCT06269705 is a clinical study titled "ZILRETTA in Subjects With Shoulder Osteoarthritis". Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo Secondary Objective: * To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with...
What is the current status of trial NCT06269705?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2024-02-05. Estimated completion is 2026-08.
What conditions does trial NCT06269705 study?
This clinical trial studies the following conditions: Glenohumeral Osteoarthritis.
What interventions are being tested in trial NCT06269705?
The interventions under investigation include: Placebo (OTHER), ZILRETTA (DRUG).
Who is sponsoring clinical trial NCT06269705?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06269705 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.